M&A Deal Summary

Certara Acquires Synchrogenix Information Strategies

On April 2, 2014, Certara acquired medical products company Synchrogenix Information Strategies

Acquisition Highlights
  • This is Certara’s 1st transaction in the Medical Products sector.
  • This is Certara’s 2nd transaction in the United States.
  • This is Certara’s 1st transaction in Delaware.

M&A Deal Summary

Date 2014-04-02
Target Synchrogenix Information Strategies
Sector Medical Products
Buyer(s) Certara
Deal Type Add-on Acquisition

Target

Synchrogenix Information Strategies

Wilmington, Delaware, United States
Synchrogenix partners with pharmaceutical and biotech companies to develop submission documents for global regulatory agencies.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Certara

Princeton, New Jersey, United States

Category Company
Founded 2008
Sector Life Science
Employees1,487
Revenue 385M USD (2024)
DESCRIPTION

Certara engages in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes. Certara was founded in 2008 and is headquartered in Princeton, New Jersey.


DEAL STATS #
Overall 2 of 11
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 11
State: Delaware M&A 1 of 1
Country: United States M&A 2 of 6
Year: 2014 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-12 Great Lakes Drug Development

Brighton, Michigan, United States

Great Lakes Drug Development, Inc. is a provider of strategic, operational and interim management support for early drug development projects.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 XenologiQ

Canterbury, United Kingdom

XenologiQ is a quantitative systems pharmacology (QSP) consultancy provider.

Buy -